The Venture Codex Logo

The Venture Codex

Saras Capital

27 New Dover Road, Canterbury, Kent, CT1 3DN, United Kingdom

Overview

Investment firm specializing in capital management.

Deals · 12mo

3

Links

WebsiteLinkedIn

Stage focus

Seed

Geographic focus

France
Germany
Ireland
United Kingdom
...

Sector focus

—

Investment portfolio

9rounds
NAMEDATESIZE
Shennon Biotechnologies
Sep 2026Participated
$12 MOther Equity
Cellbyte
Nov 2025Participated
$3 MSeed
Modulight Biotherapeutics
Nov 2025Participated
$12 MSeed
Aerska
Oct 2025Participated
$21 MSeed
Kyron.bio
May 2025Participated
$6 MSeed
Generare
Oct 2024Participated
$6 MSeed
Infinitopes
May 2024Participated
$16 MSeed
Parse Biosciences
Dec 2023Participated
$50 MSeries C
Eden Bio
Nov 2022Participated
$1 MSeed
Shennon Biotechnologies
Sep 2026Participated
$12 MOther Equity
Cellbyte
Nov 2025Participated
$3 MSeed
Modulight Biotherapeutics
Nov 2025Participated
$12 MSeed
Aerska
Oct 2025Participated
$21 MSeed
Kyron.bio
May 2025Participated
$6 MSeed
Generare
Oct 2024Participated
$6 MSeed
Infinitopes
May 2024Participated
$16 MSeed
Parse Biosciences
Dec 2023Participated
$50 MSeries C
Eden Bio
Nov 2022Participated
$1 MSeed
9
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Saras Capital: 9 funding rounds are recorded in the selected participation categories.All available history.
Saras Capital: 9 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed07
Series C+01
Other Equity01

Monthly Deal Activity

Saras Capital: 9 deals are recorded across 48 months.All available history.
Saras Capital: 9 deals are recorded across 48 months. All available history
MonthDeals
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '252
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Saras Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Saras Capital: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
AI & Machine Learning3
Space & Frontier Tech2
Marketing & Advertising1
Data, Analytics & IT1

Deal Size Distribution

Saras Capital: 9 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Saras Capital: 9 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M4
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Saras Capital: Europe has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Saras Capital: Europe has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
Europe6
United States3
Saras Capital: 20 co-investors are shown, with SynBioVen sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Saras Capital: 20 co-investors are shown, with SynBioVen sharing 2 recorded deals. All available history
Co-investorShared deals
SynBioVen2
Ada Ventures1
age11
Atypical Ventures1
AV8 Ventures1
Backed1
Better Angle1
Bioeconomy Capital1
BlueYard Capital1
Cancer Research Horizons1
Cancer Research Institute1
CRIS Cancer Foundation1
Data Collective1
Dhyan Capital1
Entrepreneur First1
Foundation Capital1
Fresh Fund1
Frontline Ventures1
Future Ventures1
Galion.exe1

Investment Strategy

Saras Capital: Led accounts for 0% and participating for 100% of round participation.All available history.
Saras Capital: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating9100%
Saras Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Saras Capital: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

No team members found for this fund.